University of Maryland, School of Medicine, Baltimore, MD, USA.
Lancet Infect Dis. 2011 Sep;11(9):692-701. doi: 10.1016/S1473-3099(11)70054-8. Epub 2011 Jun 12.
In much of the world antimicrobial drugs are sold without prescription or oversight by health-care professionals. The scale and effect of this practice is unknown. We systematically reviewed published works about non-prescription antimicrobials from 1970-2009, identifying 117 relevant articles. 35 community surveys from five continents showed that non-prescription use occurred worldwide and accounted for 19-100% of antimicrobial use outside of northern Europe and North America. Safety issues associated with non-prescription use included adverse drug reactions and masking of underlying infectious processes. Non-prescription use was common for non-bacterial disease, and antituberculosis drugs were available in many areas. Antimicrobial-resistant bacteria are common in communities with frequent non-prescription use. In a few settings, control efforts that included regulation decreased antimicrobial use and resistance. Non-prescription antimicrobial and antituberculosis use is common outside of North America and northern Europe and must be accounted for in public health efforts to reduce antimicrobial resistance.
在世界上许多地方,抗菌药物无需处方或医疗专业人员监督即可销售。这种做法的规模和影响尚不清楚。我们系统地回顾了 1970 年至 2009 年发表的关于非处方抗菌药物的文献,共确定了 117 篇相关文章。来自五大洲的 35 项社区调查表明,非处方使用在全球范围内普遍存在,占北欧和北美以外地区抗菌药物使用的 19%至 100%。与非处方使用相关的安全问题包括药物不良反应和掩盖潜在的感染过程。非处方用于非细菌性疾病很常见,许多地区都有抗结核药物。在经常非处方使用抗菌药物的社区中,常见对抗菌药物耐药的细菌。在一些地方,包括监管在内的控制措施减少了抗菌药物的使用和耐药性。在北美和北欧以外地区,非处方使用抗菌药物和抗结核药物很常见,在减少抗菌药物耐药性的公共卫生工作中必须考虑到这一点。